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Cyanobactins, a class of ribosomally encoded mac-
rocylic natural products, are biosynthesized through
the proteolytic processing and subsequent N-C
macrocylization of ribosomal peptide precursors.
Macrocylization occurs through a two-step process
in which the first protease (PatA) removes the amino
terminal flanking sequence from the precursor to
yield a free N terminus of the precursor peptide,
and the second protease (PatG) removes the
C-terminal flanking sequence and then catalyzes
the transamidation reaction to yield an N-C cyclized
product. Here, we present the crystal structures of
the protease domains of PatA and PatG from the
patellamide cluster and of PagA from the prenyl-
agaramide cluster. A comparative structural and
biochemical analysis of the transamidating PatG
protease reveals the presence of a unique structural
element distinct from canonical subtilisin proteases,
which may facilitate the N-C macrocylization of the
peptide substrate.
INTRODUCTION
Small molecule peptide natural products continue to represent
major avenues towards the development of new antibiotics
and antiproliferatives. Many of these natural products exhibit
potent biological activities against a number of therapeutic
targets, and the range of schemes for the biosynthesis of such
molecules gives rise to a diversity of structures (Fischbach and
Walsh, 2009; Newman and Cragg, 2007). The structural diversity
of ribosomally synthesized peptides has only begun to be appre-
ciated with the realization that such peptides can undergo
a range of posttranslational modifications.
One modification that is prevalent in peptide natural products
is macrocyclization, which brings together distant parts of an
otherwise elongated molecule in close proximity. Examples of
such ribosomally synthesized and posttranslationally modified
peptides (RiPPs) that contain macrocycles include lantibiotics
that contain (methyl)lanthionine-containing thioethers (Figure 1A)
(Knerr and van der Donk, 2012), thiopeptides that are con-Chemistry & Biology 19, 1411–142strained through pyridine rings generated by Diels-Alder-type
condensations (Figure 1B) (Walsh et al., 2010), and thuricin and
subtilosin bearing sulfur-a carbon thioethers (Flu¨he et al., 2012;
Rea et al., 2010) (Figure 1). Cyclic peptides are widely sought
in pharmaceutical discovery and development because their
constrained structures often provide better target specificity
and improved pharmacological and stability properties in com-
parison to their linear relatives. Macrocyclization also provides
rigidity to the structure of themolecules and can also confer ther-
mostability and chemical resistance to the cyclized natural
product (Garg et al., 2012).
Cyanobactins (Figures 1C–1E) are a class of RiPPs that are
found in greater than 30% of all cyanobacteria. In contrast to
many other macrocyclic natural products, cyanobactins are
macrocyclized via the peptide backbone and not via amino
acid side chains. All cyanobactins are synthesized as precursor
peptides (‘‘PatE’’ and relatives) that are matured by two prote-
ases, exemplified by PatA and PatG in the patellamide biosyn-
thetic pathway (Figure 2) (Lee et al., 2009; Schmidt et al.,
2005). In addition to macrocyclization, cyanobactins may con-
tain Ser, Thr, and Cys residues, which are heterocyclized with
the main-chain atoms to yield (methyl)oxazoline and thiazoline
five-membered rings (McIntosh et al., 2010a; McIntosh and
Schmidt, 2010). Further enzymatic oxidation of these rings yields
(methyl)oxazole and thiazole rings. Other posttranslational modi-
fications include prenylation at Ser/Thr or Tyr/Trp residues cata-
lyzed by the PatF class of prenyltransferases (McIntosh et al.,
2011). Metagenomic studies have revealed the widespread
presence of homologs of patellamide biosynthetic genes in the
marine microbiota, such as trunkamides, prenylagaramides,
and arthrospiramides (Donia and Schmidt, 2011; Schmidt and
Donia, 2009; Sivonen et al., 2010). The biosynthetic route for cy-
anobactins represents one of the most broad substrate RiPP
pathways so far characterized and represents an ideal starting
point for engineering and genomemining approaches to peptide
macrocyclization.
Intriguingly, despite being paralogs that are very sequence
similar (greater than 40% similarity), PatA and PatG catalyze
quite biochemically distinct reactions. PatA recognizes a five-
amino acid sequence on the PatE coding cassette as a site for
cleavage, synthesizing short, linear peptides. In turn, these pep-
tides are substrates for PatG, which recognizes a three-amino
acid C-terminal sequence (Lee et al., 2009). PatG cleaves this
sequence from the core peptide and macrocyclizes the product.2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1411
Figure 1. Chemical Structures of Representative Macrocyclized Natural Products
(A) Lantibiotic nisin.
(B) Thiopeptide thiocillin I.
(C) Cyanobactin patellamide A.
(D) Cyanobactin trunkamide.
(E) Cyanobactin prenylagaramide B. The macrocyclizing covalent bonds are highlighted in red. Five membered heterocycles in patellamide A and trunkamide are
highlighted. Prenylagaramide is devoid of heterocycles.
(F) Primary sequence alignment of the PatE, TruE, and PagE substrate peptide primary sequences. The hypervariable cyanobactin cassette residues (shown by
dashed line above the sequence) are denoted by X. The cyanobactin cassettes are flanked by conserved sequences at the N termini and C termini (shaded green
and yellow, respectively). Note that the last residue of the cyanobactin coding cassette (in bold and marked by: under the sequence) is a cysteine residue (for
PatE and TruE) which is subsequently heterocyclized, or a heterocycle mimicking proline residue (for PagE).
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are hypervariable, whereas the flanking regions are highly con-
served, leading to sequence-diverse macrocycles. The pres-
ence of diverse posttranslational modifications, paired with the
hypervariable core peptide, has resulted in >200 known cyano-
bactin natural products and >70 widely sequence-diverse, engi-
neered derivatives that we have previously reported (Donia et al.,
2008; Donia and Schmidt, 2011; Tianero et al., 2012). In addition,
there are many other homologous cyanobactin pathways that
have different recognition elements and lead to different prod-
ucts (Donia et al., 2006, 2008; Donia and Schmidt, 2011).1412 Chemistry & Biology 19, 1411–1422, November 21, 2012 ª2012We previously showed that just the protease domains of
PatA and PatG are sufficient to recapitulate activity in vitro (Lee
et al., 2009). As discerned from the many known cyanobactin
gene clusters, PatA, PatG, and their homologs fall into a single
family (clade) within the large subtilisin protease group (Donia
and Schmidt, 2011). By carefully manipulating substrates, we
showed that PatG follows the normal subtilisin-like proteolytic
route, where substrates are cleaved and become covalently
bound to the active-site Ser (McIntosh et al., 2010b). Subse-
quently, displacement by the internal amine nucleophile leads
to transamidation and macrocyclization. We also observed theElsevier Ltd All rights reserved
Figure 2. The Proposed Enzymatic Scheme for the Biosynthesis of
Patellamide and Related Cyanobactins
For clarity, only one substrate cassette for PatE is shown. The conserved
amino acids flanking the amino and carboxy termini of the Pat cassettes are
colored as in Figure 1, with the coding cassette hypervariable amino acids
shown as spheres. Note that the terminal coding cassette residue is a cysteine,
which is heterocyclized and oxidized to a thiozole. A proline residue is present
in PagE at this position, and a proline can substitute for cysteine in PatE.
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substrates. The recent structure determination of the PatG
protease domain provided strong evidence in support of this
mechanistic hypothesis (Koehnke et al., 2012).
Here, we have biochemically determined the domain bound-
aries of the protease domains of both of the patellamide
processing enzymes and the first protease from the prenylagar-
amide cluster. We also report high-resolution crystal structures
of PatA, PagA, and PatG that elucidate the key features respon-
sible for the different substrate recognition and reactivities of the
enzymes. A comparison of the structures reveals the presence of
an unexpected insert in the PatG protease domain, which may
provide a molecular rationale for the macrocyclization reaction.
The structures serve to explain how highly related paralogs
promote such different chemical reactions, leading to a broad
array of RiPP natural products with therapeutic potential. It
should be noted that the in vitro activity for both the PatA
protease domain and the PatG protease domain structures
described in this study has been experimentally established
(McIntosh et al., 2010b, 2011).
RESULTS AND DISCUSSION
Determination of Cyanobactin Protease Domain
Boundaries
Cyanobactin gene clusters identified via metagenomic
approaches are characterized by the presence of two distinct
open reading frames (ORFs) that encode for subtilisin-like
proteases. The proteases do not typically exist as independentChemistry & Biology 19, 1411–142units but are rather domains of 300–360 residues that are
embedded within much larger multidomain ORFs (Lee et al.,
2009). For homologs of patA, the protease domain is localized
at the amino terminus of the corresponding ORF, followed by
a linker region and a domain of unknown function (DUF3) at the
carboxy terminus. This domain organization is conserved among
all patA homologs that have been sequenced from homologous
gene clusters (Figure 3A). For homologs of patG, the protease
domain can either be localized to the amino terminus followed
by a DUF domain or be sandwiched between an amino terminal
flavin-dependent oxidase domain and the carboxy terminal DUF
domain (Figure 3B). In protease-containing ORFs that do not
have the amino-terminal oxidase domain, the oxidase may be
present as a stand-alone ORF (Thc cluster) or be totally absent
(Pag cluster) (Donia and Schmidt, 2011).
Attempts at heterologous production and purification of full-
length ORFs encompassing the PatA and PatG proteases (as
well as other homologs) in Escherichia coli yielded only impure
and proteolytically degraded protein samples, which could not
be resolved by mutation of the active site Ser to Ala to prevent
autoprocessing. Consequently, further attempts at protein pro-
duction focused solely on the respective protease domains,
the domain boundaries of which were determined by a combina-
tion of sequence analysis and biochemical experiments. Se-
quence analysis identifies a putative PatA protease recognition
motif (Ser299-Val300-Glu301-Ala302-Ser303), which precedes
the proline-rich sequence presumed to be the linker that
connects the protease and DUF domains. We speculated that
this sequence likely constitutes the carboxy terminus of the
protease domain and generated an expression construct span-
ning residues Met1 through Ser303 of PatA. Heterologous
expression of this domain in E. coli yielded soluble and stable
protein samples that were catalytically active. Further refinement
of the domain boundaries using mass spectrometric analysis of
limited trypsin digests identified a stable domain from which the
carboxy terminal 20 residues were removed (i.e., Met1-Ala284).
Although diffraction quality crystals could only be obtained for
the larger construct, continuous electron density could only be
observed up to Ala284, validating residues Met1-Ala284 as the
PatA protease domain boundary. The domain boundaries for
the PagA homolog from the prenylagaramide cluster were
similarly established and a construct encompassing residues
Met1 through Ser303 was used for further studies. Alignment
of the PatG primary sequence with those of PatA and PagA
demonstrates that PatG residues encompassing Lys514 through
Gly850 are homologous to the PatA and PagA protease
domains. A slightly larger construct that extends through to
Thr866 at the carboxy terminus was also generated. The
protease domains of both PatA and PatG were demonstrated
to be catalytically proficient at levels comparable to those of
the corresponding wild-type enzymes (McIntosh et al., 2010b,
2011).
Crystal Structure of the PatA and PagA Protease
Domains
Crystals of the PatA protease domain (Met1 through Ser303;
hereafter PatA) diffract to 1.7 A˚ resolution (one molecule in the
crystallographic asymmetric unit) at an insertion device synchro-
tron source (Station 21 ID-D; Argonne National Labs, Lemont, IL,2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1413
Figure 3. Domain Organization of the Cyanobactin Protease ORFs and Homology between the PatA and PatG Protease Domains
(A) The PatA homologs are organized as an N-terminal protease domain (colored yellow), followed by a linker region, and a C-terminal DUF domain (colored blue).
Primary sequence numbering for PatA is shown.
(B) The PatG homologs are organized as a protease domain, followed by the C-terminal DUF domain. Variability is found in the N-terminal organization of PatG
homolog sequences, with the PatG sequence harboring an additional DUF domain, followed by a flavin-dependent oxidase domain. In the ThcG sequence, an
additional S-adenosyl-methionine-dependent methyltransferase (SMT) domain is present between the protease and DUF domains. Primary sequence
numbering for PatG is shown.
(C) Sequence alignment of PatA and PatG identifies homology between the protease and DUF domains. The amino acids corresponding to the capping helices in
PatG are boxed. The catalytic triad residues are shownwith (:) under the residues. See Figure S1 for solution oligomerization states of the cyanobactin proteases.
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Crystallographic phases were determined by single-wavelength
anomalous dispersion methods from data collected on crystals1414 Chemistry & Biology 19, 1411–1422, November 21, 2012 ª2012grown from selenomethionine-labeled protein, which grew in a
different, but related, crystal formwith twomolecules in the crys-
tallographic asymmetric unit. The protein behaves as amonomerElsevier Ltd All rights reserved
Table 1. Data Collection, Phasing, and Refinement Statistics
PatA SeMet PatA PagA PatG
Data collection
Space group P41 P4 I212121 C2
a, b, c (A˚), b () 83.7, 83.7, 42.3 117.4, 117.4, 42.6 49.7, 145.9, 193.5 133.9, 66.9, 105.6
90 90 112.2
Resolution (A˚)a 50–1.7 (1.76–1.7) 50–1.9 (1.97–1.9) 50–2.45 (2.54–2.45) 50–2.0 (2.07–2.0)
Rsym (%)
b 8.3 (66.1) 7.7 (38.6) 8.2 (49.1) 8.0 (44.3)
I/s(I) 43.5 (1.5) 43.2 (5.0) 17.2 (1.7) 22.6 (2.3)
Completeness (%) 97.4 (75.6) 100 (100) 93.2 (67.2) 96.5 (76.9)
Redundancy 12.2 (3.5) 9.3 (8.3) 6.2 (5.3) 7.1 (4.6)
Phasing
FOM/DM FOMc 0.350/0.646
Refinement
Resolution (A˚) 25.0–1.7 25.0–1.9 25.0–2.45 25.0–2.00
No. reflections 30,147 43,969 23,255 53,640
Rwork / Rfree
d 20.9/24.4 21.3/24.9 18.9/23.1 20.0/24.3
Number of atoms
Protein 1,992 3,949 4,052 4,541
Water 237 236 156 442
B-factors
Protein 27.0 28.0 47.8 32.4
Water 40.9 35.5 44.3 42.9
Rmsd
Bond lengths (A˚) 0.009 0.010 0.007 0.009
Bond angles () 1.24 1.33 1.27 1.16
aHighest resolution shell is shown in parentheses.
bRsym = S j(Ii - < I > j S Ii, where Ii = intensity of the ith reflection and < I > = mean intensity.
cMean figure of merit before and after density modification.
dR factor = S(jFobsjkjFcalcj)/S jFobsj and Rfree is the R value for a test set of reflections consisting of a random 5% of the diffraction data not used in
refinement.
Chemistry & Biology
Structures of Cyanobactin Protease Enzymesin solution and in the crystal (Figure S1 available online). Crystals
of the PagA protease domain (Met1 through Ser303; hereafter
PagA) diffract to 2.45 A˚ resolution, and crystallographic phases
were determined by molecular replacement using the refined
coordinates of PatA (66% identity) as a search probe.
The overall architectures of PatA and PagA are that of the
canonical a/b protease fold first observed in the structure of
subtilisin (Siezen and Leunissen, 1997) (Figures 4A and 4C). As
the structures of PatA and PagA are essentially identical, further
discussion will be based on the higher resolution PatA structure.
The overall topology of the PatA protease domain consists of
a seven membered central b sheet decorated on either side by
a helices. The last strand of this central sheet terminates into
two additional b strands, followed by a 22-residue a helix (helix
a6; numbered consecutively from the N terminus to the C
terminus). Helix a6 is rigidly held in place by numerous hydro-
phobic interactions with the central b sheet and with the helices
around the b sheet.
The catalytic requisite Ser218 resides at the amino terminus of
helix a6. The helix dipole moment, in addition to the serine pro-
tease catalytic triad, likely aids in the deprotonation of Ser218
to generate the nucleophilic serine alkoxide for catalysis. Two
disulfide bonds, between Cys156 and Cys158, and betweenChemistry & Biology 19, 1411–142Cys258 and Cys269, respectively, interconnect the loop
emanating from the central sheet b6 and the loop joining the car-
boxy terminus of helix a7and the amino terminus of helix a8. Both
b6 and a7 contact the helix a6 that harbors Ser218. Because
of the absence of suitable electron density, a five amino acid
flexible loop, comprising residues Ala45 through Ser51 that
connects b2 and a1 is not modeled in the final structure.
An alignment of the PatA protease domain structure with
various forms of a highly homologous serine protease subtilisin
Carlsberg (Neidhart and Petsko, 1988) (rmsd 1.7 A˚ over 232
aligned residues) provides insights into the positioning of the
amino acids proximal to the PatA catalytic triad. The PatA loop
bearing residues Val40 through His58 (and containing the
disordered residues Ala45 through Ser51) points inward
toward the active site, and the positioning of this loop in PatA
is identical in all three crystallographically independent copies
of the model described above (Figure 4A). By analogy, the
equivalent loop in subtilisin Carlsberg apo structure (PDB ID
code 1SCA) (Fitzpatrick et al., 1993) and subtilisin Carlsberg
structure in complex with the Eglin C inhibitor (PDB ID code
1CSE) (Bode et al., 1987) is directed away from the active
site. A number of interactions stabilize the position of the
Val40-His58 loop near the PatA catalytic triad, including2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1415
Figure 4. Crystal Structure of the PatA and PagA Protease Domains
(A) The a helices of PatA are colored cyan, with the central beta sheet colored blue. The loop region comprising residues 45–57, which connects the PatA
b sheet 2 and a helix 1 is shown in pink with amino acids numbered. Note that the amino acids 46–50 are missing in the final model. The catalytic triad residues
are shown in stick-ball representation with the carbon atoms colored yellow.
(B) The a helices of the PagA enzyme are colored cyan, with the central beta sheet colored green. The loop region comprising residues 45–60 is shown in pink
with the amino acids numbered. Note that amino acids 46–55 aremissing in the final model. The catalytic triad residues are shown in stick-ball representationwith
the carbon atoms colored yellow. In contrast to PatA residues 51–57, PagA residues 56–60 point away from the PagA catalytic triad.
(C) Zoomed in view of the PatA catalytic triad residue side chains. The residues are labeled. Superimposed is a difference Fourier electron density map (contoured
at 2.0s over background in blue) calculated with coefficients jFobsj  jFcalcj and phases from the final refined model with the coordinates of the catalytic triad
residue side chain atoms deleted prior to one round of refinement. Note that the positioning of the His58 side chain precludes hydrogen bonding with Asp23 and
Ser218 side chains.
(D) Zoomed in view of the PagA catalytic triad residue side chains. The residues are labeled. Superimposed is a difference Fourier electron density map (con-
toured at 2.0s over background in blue) calculated as before. Note that the positioning of the His61 side chain allows for hydrogen bonding with Asp26 and
Ser221 side chains.
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carbonyl oxygen of Gly53 and main-chain amide of Gly121,
and van der Waals contact between Phe54 and Met55.
Active-Site Architecture of the PatA/PagA Protease
By sequence analogy to serine proteases, the catalytic triad in
PatA protease domain is comprised of residues Asp23-His58-
Ser218 (Figure 4C), and the PagA triad is composed of Asp26-
His61-Ser221 (Figure 4D) (analogous to Asp32-His64-Ser221
in subtilisin Carlsberg). Although the PagA triad superimposes
nearly perfectly with that of subtilisin, the catalytic triad in the
PatA structures is imperfectly positioned. The imidazole side
chain of PatA His58, which should be positioned in between
and within hydrogen bonding distance of both Asp23 and
Ser218, points away from the enzyme active site (Figure 4C). In
PatA, Ser56 occupies the site of the catalytic triad histidine, sug-
gesting that the PatA protease domain is not preorganized for
efficient catalysis (Figure 4A). In marked contrast, the equivalent
loop in PagA is situated away from the active site (Figure 4B), and
as a result, His61 in PagA is positioned within hydrogen bonding1416 Chemistry & Biology 19, 1411–1422, November 21, 2012 ª2012distance to both Asp26 and Ser221 to form a competently orga-
nized catalytic triad (Figure 4D).
The noncanonical position of His58 in PatA is a consequence
of the orientation of Val40-His58 loop in the proximity of the
active site. In the structures of PatA, this loop spans 19 residues,
whereas the equivalent loop is 12 residues in PagA and 13 resi-
dues in subtilisin Carlsberg. Consequently, conformational
changes must be necessary for the PatA active site to adopt
a catalytically proficient state. These conformational changes
may be conferred by binding of the substrate, or by the absent
PatA C-terminal DUF domain. Nonetheless, the PatA protease
domain was fully catalytically active similar to the full-length
protein that was previously expressed (Lee et al., 2009). The
protease domain construct was completely stable even after
extensive enzymatic reactions, whereas the previously reported
PatA protein was active but unstable.
Crystal Structure of the PatG Protease Domain
The crystal structure of the PatG protease domain (resi-
dues Lys514-Thr866; hereafter PatG) was determined by theElsevier Ltd All rights reserved
Figure 5. Crystal Structure of the PatG Protease Domain
(A) The a/b core of the enzyme is colored cyan, with the capping helices
colored brown. The capping helices are numbered. The catalytic triad residues
are shown in stick-ball representation with the carbon atoms colored yellow.
(B) Zoomed in view of the PatG catalytic triad residue side chains. The residues
are labeled. Superimposed is a difference Fourier electron density map
(contoured at 2.0s over background in blue) calculated as before. See
Figure S2 for contribution of capping domain residues Lys594 and Lys598
catalysis.
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PatG are highly homologous (Figure 5A). Almost all of the PatA
secondary structural elements can be superimposed directly
upon the PatG structure, with even loop residues aligning in
near identical fashion. The catalytic nucleophile Ser783 is
analogously positioned at the amino terminus of the long a helix,
with Asp548 and His618 completing the PatG catalytic triad
(Figure 5B).
A superposition of the PatG structure with PatA (and other
homologous subtilisin-like proteases) identifies the presence of
the two additional a helices that link the fifth and sixth strands
of the central b sheet of PatG. These two helices are located
directly above the catalytic Ser783 and have hence been termedChemistry & Biology 19, 1411–142the ‘‘capping helices’’ (Figure 5A). These helices comprise
residues Pro579 to Val605 and are absent in the primary
sequences and structures of PatA and other subtilisin proteases.
Hence, the presence of the capping helices is unique to PatG
and cyanobactin orthologs that presumably catalyze N-C trans-
amidation reactions during the biosynthesis of other cyanobac-
tins. It should be noted that the PatG protease domain construct
described here has been experimentally demonstrated to be
sufficient to catalyze the macrocyclizing transamidation reaction
in cyanobactin biosynthesis (McIntosh et al., 2010b).
The first helix of the capping domain (PatG residues Pro579-
Gln591) is rigidly held into place, relative to other secondary
structure elements, by a number of hydrogen bonds and hydro-
phobic interactions. Primary among these is the salt bridge inter-
action between the side chain of Arg589 and Asp617. Hydrogen
bonds also exist between the side chains of Tyr582 and Gln586
and the side chains of Asn616 and Gln770, respectively. The
Gln586 side chain amide is also hydrogen bonded to the main-
chain carbonyl oxygen atom of Pro771. The side chain of
Phe585 makes hydrophobic van der Waals contacts with the
side chains of Leu602, Ile613, and Val614. The second helix of
the PatG protease-capping domain (residues Lys596-Val605)
does not displaymany interactions with the enzyme core domain
as seen for the first helix of the capping domain. A solitary salt
bridge exists between the side chains of Glu603 and Lys610.
This likely provides for mobility in the positioning of the second
helix of the capping domain, which is also reflected in the rela-
tively higher thermal (B) factor values for the residues of this helix.
Probable Mechanism for PatG Catalyzed
Transamidation
Formation of amide bonds during the biosynthesis of small mole-
cule natural products is driven by the activation of an amino acid
at the carboxy terminus by either phosphorylation (Blasiak and
Clardy, 2010; Hollenhorst et al., 2009) or adenylation (Kadi
et al., 2007). This activation results in conjugation of the carboxyl
with a suitable leaving group, which facilitates nucleophilic con-
densation with deprotonated primary amine of the incoming
amino acid. Another example is the amide bond formation cata-
lyzed by nonribosomal peptide synthetases, in which an amino
acid is first adenylated before being covalently tethered via
a labile thioester to a phosphopantheinenylated peptidyl carrier
protein (PCP). Lastly, covalent tethering of the carboxy terminus
to tRNA molecules via an ester linkage has also been demon-
strated for amide bond generation in small molecule natural
product biosynthesis (Vetting et al., 2010; Zhang et al., 2011).
For each of these cases, activation of the carboxy terminus is
achieved by hydrolysis of an ATP molecule; hence, such
amide-bond-forming reactions are co-factor-dependent.
In contrast, amide bond formation by PatG is not driven by
ATP hydrolysis or by tethering to PCP or tRNA molecule.
Instead, the carboxy terminus of the cyanobactin cassette is
linked by an amide bond to conserved flanking residues and is
activated by virtue of formation of an acyl-enzyme intermediate
with the catalytic Ser of the macrocyclizing protease.
For all of the cases listed above, there are two mechanistic
requirements that need to be satisfied. The first is the spatial
positioning of the modified carboxy terminus in close physical
proximity to the incoming primary amine within the enzyme2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1417
Figure 6. Proposed Mode of Substrate Binding and Reaction Mechanism for the Macrocyclizing Amide Bond Formation by the PatG
Protease Domain
The patellamide cassette wraps in the interior of the capping helices, which also serve to deprotonate the amino terminus of the cyanobactin coding cassette
generated by the proteolytic action of PatA (highlighted in blue). The PatG catalytic triad catalyzes the first half reaction, causing the scission of the conserved
carboxy terminus flanking region (highlighted in yellow) and generating the acyl enzyme intermediate. The capping helices maintain the active site in a desolvated
state and position the amino terminus in close proximity to the acyl enzyme intermediate, in order to bias the second half reaction toward aminolysis, rather than
hydrolysis. Xn denotes the first (R1) and last (Rn+2) amino acids of the cyanobactin coding cassette.
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should be deprotonated by a catalytic base (enzyme Tyr, Lys,
or Arg side chain), so as to generate the nucleophile for
attack at the activated ester or thioester. The active site can
also modulate the pKa of the primary amine by positioning it in
a hydrophobic or a positively charged cavity.
Within the PatG active site, spatial positioning of the carboxy
terminus relative to the incoming primary amine may be medi-
ated by the ‘‘capping helices’’ that are unique to this enzyme.
The substrate peptide wraps around in the interior of the
active site in the pocket formed by the capping helices. Binding
would be primarily mediated by the backbone carbonyl oxygen
atoms of the substrate peptide with the positively charged
interior electrostatic surface of the PatG capping helices. The
catalytic Ser783 of PatG would attack the carbonyl carbon of
the scissile amide bond to generate a tetrahedral hemiketal
intermediate. The intermediate would be resolved by the depar-
ture of the C-terminal flanking peptide (Ala-Tyr-Asp-Gly-Glu) of
the Pat cassette to yield the covalent acyl-enzyme complex
(Figure 6).
Conformational flexibility of the second helix of the capping
domain would then allow for the substrate peptide amino
terminus to approach the esterified acyl enzyme intermediate.
The positively charged interior surface of the PatG capping
helices could lower the pKa of the nucleophile amine, and either
of two appropriately positioned Lys side chains—Lys594 or
Lys598—could act as a general base. A second nucleophilic
attack would lead to the formation of a second hemiketal inter-
mediate, which would be resolved by the departure of the serine
side chain to yield an amide bond (Figure 6). In order to facilitate
the second nucleophilic addition by the amino terminus of the1418 Chemistry & Biology 19, 1411–1422, November 21, 2012 ª2012Pat cassette, the PatG active site would need to be desolvated
to protect the ester intermediate from nucleophilic attack by
a water molecule to yield a linear Pat cassette as the product.
The four heterocycles in the PatE substrate peptide may help
to constrict conformational flexibility and offset the entropic
cost of binding an otherwise flexible peptide within the con-
straints of the PatG active site. Notably, the TruG protease
(82% sequence identity, 91% sequence similarity with PatG)
functions on a peptide substrate that contains only a single
heterocycle, and the PatG protease can macrocyclize a variety
of peptidic and nonpeptidic substrates (McIntosh et al.,
2010b). These data argue that prearrangement of the substrate
in a near-cyclical conformation is not a strict requisite for
macrocyclization.
The poor catalytic activity of the PatG enzyme (Lee et al., 2009;
McIntosh et al., 2010b) precludes determination of the kinetic
parameters for the wild-type enzyme and the contribution of
Lys594 and Lys598 side chains toward catalysis. The Lys594/
Lys598/Ala double mutant was constructed, and its reactivity
with two substrates (Lys-Lys-Pro-Tyr-Ile-Leu-Pro-Ala-Tyr-Asp-
Gly-Glu and Lys-Gly-Gly-Arg-Gly-Asp-Trp-Pro-Ala-Tyr-Asp-Gly-
Glu) is similar to the wild-type enzyme. A closer inspection of the
time course of reaction of the first substrate peptide with the
PatG 513-866 wild-type enzyme revealed the formation of cyclic
product after only 3 hr (Figure S2), whereas no product could be
observed with the PatG 513-866 Lys594/Lys598/Ala double
mutant enzyme during this time (Figures S2B and S2C). A longer
incubation of up to 48 hr converted nearly all of the substrate to
a mixture of linear and the cyclic product by both enzymes,
which leads us to postulate that mutation of Lys594/Lys598/
Ala slows the rate of the reaction but does not alter the overallElsevier Ltd All rights reserved
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tive nature of MALDI-MS, and a full kinetic analysis needs to be
performed to definitively quantitate the contribution of Lys594
and Lys598 residues toward catalysis. However, because of
the poor activity of the enzyme, only a semiquantitative
approach could be used to characterize site-specific variants.
The recent work of Koehnke et al. (2012) shows two clear
effects ofmutating Lys594 and Lys598 to Asp. Lys598was found
important for interacting with the Asp residue in the flanking
peptide (Ala-Tyr-Asp-Gly). When Lys598Asp PatG was assayed
with a substrate with altered recognition sequence Ala-Tyr-Arg-
Gly, which would restore the polar interaction between Lys598
and the flanking sequence, there was an order of magnitude
improvement in activity over wild-type enzyme with the native
Ala-Tyr-Asp-Gly recognition sequence. Lys594Asp reacted
very slowly with the altered Ala-Tyr-Arg-Gly substrate. Both
lysine residues are also important for cyclization of the product.
In wild-type assays, Koehnke and colleagues found that the
cyclic product was formed from the substrate Val-Gly-Ala-Gly-
Ile-Gly-Phe-Pro-Ala-Tyr-Asp-Gly, whereas mutation of one
lysine caused the enzyme to produce a mixture of linear and
cyclic products (Lys594Asp) or only linear product (Lys598Asp).
They hypothesized that after the first step in the reaction (peptide
cleavage), the Ala-Tyr-Asp-Gly product remains in the active
site, preventing hydrolysis of the covalently bound intermediate
to form the linear product. Our double mutation of both lysines
to alanine did not give the same effect on production of
cyclic and linear products as the Lys/Asp mutations. In assays
with peptide Lys-Lys-Pro-Tyr-Ile-Leu-Pro-Ala-Tyr-Asp-Gly-Glu,
we observed similar mixtures of cyclic and linear products
from wild-type and mutant enzymes, whereas with substrate
Lys-Gly-Gly-Arg-Gly-Asp-Trp-Pro-Ala-Tyr-Asp-Gly-Glu, we ob-
served only cyclic products in assays of both enzymes. In
addition to contacts between the lysine residues and aspartate
in the recognition sequence Ala-Tyr-Asp-Gly, there are also
hydrophobic interactions and hydrogen bonds between tyrosine
of the recognition sequence and the enzyme (Koehnke et al.,
2012). If the hypothesis that the Ala-Tyr-Asp-Gly product
remains in the active site to exclude water and favor production
of cyclic products is correct, mutation of Lys594 and Lys598 to
Ala may still allow for good binding of the recognition sequence
and a small effect on activity, relative to the mutation of these
residues to aspartate. A relatively small effect of mutating these
lysines on the overall catalytic rate may also be expected in the
case that either lysine acts as a general base to deprotonate the
N terminus of the peptide, if this step is not rate-limiting.
The slow rate of the PatG reaction makes it difficult to study
the kinetic effects of various mutations on the enzyme. We
have tried many different buffers without finding conditions
that significantly increased the rate. Koehnke et al. (2012) re-
ported a large improvement in product conversion by raising
the salt concentration and raising the pH or including DMSO in
reactions. When we assayed PatG under these conditions, the
relative rate was not greatly improved for one of the best
substrates, Lys-Lys-Pro-Tyr-Ile-Leu-Pro-Ala-Tyr-Asp-Gly-Glu,
leading us to believe that acceleration may be due at least in
part to buffer effects on substrates rather than directly on the
enzyme.The poor activity of the wild-type enzyme may be attrib-
uted to the absence of additional cis-acting domains or trans-Chemistry & Biology 19, 1411–142interaction of the protease domain with other proteins in the
patellamide biosynthetic pathway. The possibility that the mac-
rocyclase catalyst has been adapted to produce only modest
levels of cyclized cyanobactin natural products under physiolog-
ical conditions also cannot be discounted because our optimal
in vivo production levels require 5 days of fermentation in
E. coli. The poor activity of the catalyst cannot, however, be
attributed to the absence of the four heterocycles, based upon
our previous biochemical studies on the substrate promiscuity
of PatG protease domain and the fact that highly similar TruG
and PatG enzymes employ physiological substrates, which
have one or no heterocycles present, respectively. Lastly, prior
experiments have characterized PatG and TruG constructs con-
taining the DUF and protease domains, and they were not mark-
edly faster than the protease-only constructs (Lee et al., 2009).
Catalytic Profiles of an Engineered PatG
Subtiligase-type Variant
The co-factor-independent peptide bond formation activity of
the PatG protease domains may also be considered in the
context of prior studies using engineered variants of subtilisin
to catalyze peptide ligation (Braisted et al., 1997). Formation of
a peptide bond by PatG relies on minimizing hydrolysis (by
solvent) and promoting aminolysis (by the substrate peptide
a-amine) of the covalent acyl-enzyme intermediate. Hydrolysis
of the intermediate yields linear Pat cassettes as products,
whereas aminolysis yields macrocyclized cyanobactins. Both
linear and macrocyclized products can be observed in in vitro
experiments with PatG (Figure 7) (McIntosh et al., 2010b).
Previous studies have shown that the equilibrium between
hydrolysis and aminolysis can be shifted by changing the
chemical nature of the covalent enzyme intermediate in subtilisin
proteases. Thioester intermediates, generated by the replace-
ment of active site Ser221 in subtilisin by Cys, are more than
600-fold more efficient for aminolysis over hydrolysis (Nakatsuka
et al., 1987). Selenol esters, containing an active-site Se-Cys,
were 14,000-fold more efficient for aminolysis (Wu and Hilvert,
1989). The molecular crowding in the active site created by
the replacement of the wild-type alcohol Ser side chain by
bulkier thiol side chain (in thiolsubtilisin) or selenol side chain
(in selenolsubtilisin) could be relieved by an additional
Pro225/Ala mutation (Abrahmse´n et al., 1991). Thus,
Ser221/Cys/Pro225/Ala subtilisin (termed as subtiligase)
could be utilized to generate entire functional proteins and
enzymes by sequential ligation of peptide fragments (Chang
et al., 1994; Jackson et al., 1994) and for the generation of cyclic
peptides (Jackson et al., 1995).
In order to explore whether similar substitutions within PatG
could offer an increase in the catalytic efficiency for macro-
cyclization, we generated the PatG protease Ser783/Cys/
Pro787/Ala variant (hereafter PatGsubtiligase) and carried out
in vitro mass spectrometric assays of this variant with different
substrates. The crystal structure of PatG establishes that
Pro787 is positioned analogously to Pro225 in subtilisin. Both
wild-type PatG and PatGsubtiligase were first assayed with the
substrate Lys-Lys-Pro-Tyr-Ile-Leu-Pro-Ala-Tyr-Asp-Gly-Glu. In
order to probe the competing reactions of hydrolysis and aminol-
ysis, the enzymatic reactions of both proteins were challenged
using the primary amines of small di-peptides. In the presence2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1419
Figure 7. Analysis of Products Generated by the Wild-type PatG,
and PatGsubtiligase for the KKPYILPAYDGE Peptide in the Presence
of Ala-Gly
(A) Analysis of products generated by wild-type PatG and PatGsubtiligase for
the KKPYILPAYDGE peptide in the presence of Ala-Gly. Top: Black shows the
MALDI-MS spectrum for the substrate peptide. Middle: Red shows the reac-
tion of the substrate peptide with wild-type PatG, whereas the bottom (in
green) shows the reaction of the substrate peptide with PatGsubtiligase.
The relevant peaks are labeled. Cyclic peptides are labeled as c. Note that the
peaks corresponding to the cyclic products in the bottom are present in the
middle. But, the peaks corresponding to linear products or linear Ala-Gly
adducts in the middle are absent in the bottom. The reaction has proceeded to
completion, as evidenced by the complete disappearance of the substrate
peaks.
(B) Analysis of products generated by the wild-type PatG protease domain
and PatGsubtiligase for the (Ahx)RGDWPAYDGE peptide. The scheme is as
before. Note that the peak corresponding to the cyclic product in the
bottom is present in the middle, but the peak corresponding to linear product
in the middle is absent in the bottom. Also note that the reaction has not
proceeded to completion. See Figures S3 and S4 for comparison of PatG and
PatGsubtiligase reactions in the presence of Gly-Gly di-peptide and formation of
cyclo[KKPYILP].
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which include linear (Lys)-Lys-Pro-Tyr-Ile-Leu-Pro peptides
(note that the first Lys residue of the substrate peptide is hydro-
lyzed nonenzymatically) (McIntosh et al., 2010b), cyclized1420 Chemistry & Biology 19, 1411–1422, November 21, 2012 ª2012peptides, and most interestingly, linear adducts of (Lys)-Lys-
Pro-Tyr-Ile-Leu-Pro with the Ala-Gly (Figure 7A). This result is
consistent with our hypothesis that the wild-type enzyme
can deacylate the ester intermediate by hydrolysis or aminolysis.
Further, the aminolysis step can also accept ‘‘trans’’-primary
amines, as provided by the Ala-Gly. This result has been
further corroborated by the presence of Gly-Gly adducts with
the same substrate peptide under similar assay conditions
(Figure S3).
When the PatGsubtiligase reaction was challenged with the
Ala-Gly dipeptide (Figure 7A) or the Gly-Gly (Figure S3), the
predominant products are the cyclized peptides and no
Ala-Gly/Gly-Gly adducts can be observed. Our preliminary qual-
itative data also suggest that PatGsubtiligase is a more competent
catalyst for cyclization via aminolysis, as compared to the wild-
type enzyme, in the absence of competing primary amines
(Figure S4). These data are consistent with the idea that the
rate-limiting step of the PatG catalytic scheme, as shown in
Figure 6, is the deacylation. When the aminolysis of the acyl-
enzyme intermediate is hastened in PatGsubtiligase, only cyclic
peptides are observed as products. The slower aminolytic de-
acylation of the wild-type enzyme allows for competition from
water, as well as small molecule primary amines, for deacylation,
which results in the formation of linear products and di-peptide
adducts, respectively.
It should be noted that Lys-Lys-Pro-Tyr-Ile-Leu-Pro-Ala-Tyr-
Asp-Gly-Glu is one of the best substrates for the PatG protease
domain enzyme that we identified in our previous extensive
substrate scope studies. We sought to explore whether
PatGsubtiligase would bias the reaction toward cyclization of the
substrate peptide for poorer substrates that are processed
very slowly by the enzyme. We assayed the activity of wild-
type PatG and the subtligase variant in presence of (Ahx)Arg-
Gly-Asp-Trp-Pro-Ala-Tyr-Asp-Gly-Glu (Ahx = aminohexanoic
acid). For this substrate, cyclization was demonstrated to occur
via the aminohexanoic acid moiety at the N terminus of the
peptide. Although the wild-type enzyme displayed a mixture of
cyclic and linear products, PatGsubtiligase exclusively produced
the cyclized product (Figure 7B).
These engineering experiments, analysis of which are
compromised by the poor catalytic efficiency of the enzyme,
lay the framework for further development of PatG as a general
promiscuous, co-factor-independent catalyst for the synthesis
of circularized peptides. The range of products that can be
generated using wild-type PatG and PatGsubtiligase may be of
broad interest for pharmaceutical and biotechnological
applications.
SIGNIFICANCE
Biosynthesis of microbial genetically encoded small mole-
cule natural products continues to provide numerous exam-
ples in which novel enzymatic chemistry can be achieved
through subtle changes in the active sites of enzymes with
well-established mechanisms. One such example is the
co-factor-independent amide bond formation activity of
the cyanobactin maturation proteases, which generates
a macrocyclic product from a linear substrate. Here, we
describe the crystal structures of the subtilisin-likeElsevier Ltd All rights reserved
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ison of the structures reveals the presence of additional
structural motifs within the PatG protease that favor transa-
midation (rather than hydrolysis) of the acyl-substrate
complex. We also present biochemical details of an engi-
neered PatG variant with improved macrocyclization
activity, while preserving the broad substrate specificity of
the wild-type enzyme.
EXPERIMENTAL PROCEDURES
Methods describing the cloning, expression, purification, and crystallization of
the various cyanobactin protease domains have been described in detail in the
Supplemental Experimental Procedures.
Phasing and Structure Determination
X-ray diffraction data were collected at Life Sciences Collaborative Access
Team (LS-CAT), Sector-21, Argonne National Laboratory. Initial crystallo-
graphic phases for the PatA protease domain were determined and solved
by single-wavelength anomalous diffraction utilizing anomalous scattering
from crystals of selenomethionine-labeled PatA protease domain. A 9-fold
redundant data set was collected at the selenium absorption edge, to a limiting
resolution of 1.9 A˚ (overall Rmerge = 0.077, I/s (I) = 5 in the highest resolution
shell) utilizing a Mar 300 CCD detector (LS-CAT, Sector 21 ID-D, Advanced
Photon Source, Argonne, IL, USA). Data were indexed and scaled using the
HKL2000 package (Otwinowski et al., 2003). A total of 15 selenium sites
were identified using HySS (Grosse-Kunstleve and Adams, 2003), and heavy
atom parameters were refined using Phaser as implemented in the Phenix
suite of programs to yield a figure of merit of 0.418 (acentric/centric = 0.452/
0.110). The resultant electron density map was of exceptional quality and
permittedmost of themain-chain andmore than half of the side-chain residues
to be automatically built using ARP/wARP. The remainder of the model was
fitted using Coot (Emsley and Cowtan, 2004) and further improved through
iterative rounds of refinement with REFMAC5 (Murshudov et al., 1997) inter-
spersed with manual rebuilding. Subsequent rounds of model building and
crystallographic refinement utilized data from a native crystal of PatA protease
domain grown under similar conditions that diffracted to 1.7 A˚ resolution.
Crossvalidation, using 5% of the data for the calculation of the free R factor,
was utilized throughout the model-building process in order to monitor
building bias (Kleywegt and Bru¨nger, 1996).
X-ray diffraction data from crystals of the PagA and PatG protease domains
were collected and processed in a similar manner. The structure of each of
these protease domains was determined by the molecular replacement
method using the refined coordinates of the PatA protease domain as a search
model (McCoy et al., 2007). The resultant solutions were subject to initial
rounds of automated model building using ARP/wARP, followed by subse-
quent rounds of manual rebuilding using XtalView, interspersed with crystallo-
graphic refinement using REFMAC5.
ACCESSION NUMBERS
Atomic coordinates have been deposited with the Protein Data Bank (http://
www.rcsb.org) with the following accession codes: PatA (4H6V), PagA
(4H6W), and PatG (4H6X).
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